Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Insulin Pens Market Outlook

The global insulin pens market size was valued at USD 41.96 million in 2023, driven by increasing prevalence of diabetes, easy to use nature of insulin pens, and improvements in global healthcare infrastructure. The market is anticipated to grow at a CAGR of 3.1% during the forecast period 2024-2032 to reach a value of USD 55.23 million by 2032.

insulin pens market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Key Trends in the Market

Insulin pens are pen-shaped devices with an injector and a reservoir where insulin can be stored. Available in disposable and reusable formats, insulin pens are used by people with diabetes who require insulin in a liquid form. Insulin pens are increasingly replacing insulin syringes because they are less painful and are easier to use as compared to the conventional syringe. Insulin pens are mostly injected in the front and side of thigh, in the abdomen, and in the outer and upper arms. 

  • Increase in the number of diabetic patients, including type 1 and type 2 diabetes, has surged the demand for insulin pens globally, helping in the growth of the overall insulin pens market. Improvements in diagnostics have increased the number of patients with a confirmed diabetes diagnosis and prescription for insulin pens.
  • Insulin pens are simple to use and give accurate results which has increased its popularity among people. Reusable insulin pens are easy to refill and lower costs of purchasing new insulin pens.
  • Developments carried out in insulin pen technology, such as smart insulin pens that can integrate with mobile apps, calculate and track doses, and provide reminders and alerts for upcoming doses, are fuelling the growth of the insulin pens market.

Market Analysis

insulin pens market by segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Based on product type, the market can be bifurcated into prefilled and reusable. By end use, the market is categorised into hospitals and clinics, ambulatory surgical centres, and home care setting. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. 

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global insulin pens market covering their competitive landscape and latest developments like mergers, acquisitions, investments, and expansion plans.  

  • Eli Lilly and Company
  • Novo Nordisk A/S
  • Biocon Limited
  • F. Hoffmann-La Roche Ltd
  • Sanofi-aventis Groupe
  • Becton, Dickinson and Company
  • Others

Market Share by End Use

Hospitals and clinics accounted for a significant share in the insulin pens market globally because they have skilled doctors and professionals with fully equipped products to diagnose and treat both type 1 and type 2 diabetic patients. Furthermore, in healthcare settings, a new insulin pen is required for every patient at every visit, increasing the number of pens used in hospitals and clinics. Patients are provided with insulin timely to improve their blood sugar levels, often in critical situations. However, home care settings are a growing end use segment for insulin pens as more people become regular users of insulin and switch to insulin pens instead of syringes. 

Market Share by Region

North America held the sizable share in the global insulin pens market owing to the widespread prevalence of diabetes in the region. Presence of a large number of key players and increasing research and development activities by them in order to improve insulin pen features and capabilities are enhancing the growth of the market in the region. Moreover, demand for smart insulin delivery products is increasing rapidly which is encouraging the manufacturers to come up with new solutions in order to fulfil their demand. In countries such as the United States, insulin pens are among the most forms of insulin delivery used by patients.

insulin pens market by region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Competitive Landscape

Eli Lilly and Company was established in 1876 and is headquartered in Indiana in the United States. It is a pharmaceutical company that carries out research and development to improve its product offerings for its customers and consumers. Eli Lilly and Company manufactures human healthcare products such as clinical depression drugs and antipsychotic medications, among other products. 

Novo Nordisk A/S was founded in 1923 is headquartered in Bagsvaerd, Denmark. It is a Danish pharmaceutical company that innovates and develops biological medicines for the healthcare industry. Their products include medicines for conditions such as diabetes, haemophilia, obesity, hormone replacement, and growth hormone therapy. Beyond medicine development, they aim to make their product accessible to every person throughout the world. 

Biocon Limited was founded in 1978 and has its headquarter in Bengaluru, India. It is a pharmaceutical company that is involved in developing biosimilars, complex APIs, and generic formulations, and supplying these products and solutions to consumers globally. It is also known for commercialising recombinant human insulin using a yeast expression system.  

Other market players include F. Hoffmann-La Roche Ltd., Sanofi-aventis Groupe, and Becton, Dickinson and Company, among others.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product Type
  • Disease Type
  • Distribution Channel
  • Region
Breakup by Product Type
  • Disposable Insulin Pen
  • Reusable Insulin Pen
Breakup by Disease Type
  • Type I Diabetes
  • Type II Diabetes
Breakup by Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Diabetes Clinics
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Nikkiso Co., Ltd.
  • Asahi Kasei Medical Co. Ltd
  • B. Braun Melsungen AG
  • Fresenius SE & Co. KGaA
  • Terumo Bct, Inc
  • Haemonetics Corporation
  • Mallinckrodt
  • Kaneka Corporation
  • Kawasumi Laboratories, Inc.
  • Miltenyi Biotec
  • Infomed
  • Toray Medical Co., Ltd.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us today for customized, data-driven solutions tailored to your unique requirements!

Key Questions Answered in the Report

The global insulin pens market reached a value of USD 41.96 million in 2023.

The market is projected to grow at a CAGR of 3.1% during the forecast period of 2024-2032 to reach a value of USD 55.23 million by 2032.

The major market drivers are increasing prevalence of diabetes, easy to use nature of insulin pens, and improvements in global healthcare infrastructure.

The key trends of the market are increase growing affordability of insulin pens, preference for refillable insulin pens in home settings, and technological advancements such as the development of smart insulin pens.

Key players in the insulin pens market include Eli Lilly and Company, Novo Nordisk A/S, Biocon Limited, F. Hoffmann-La Roche Ltd., Sanofi-aventis Groupe, and Becton, Dickinson and Company, among others.

An insulin pen is an injector device in the shape of a pen with a reservoir to store insulin that is used to inject insulin in people suffering from diabetes.

Insulin pens are considered less painful than insulin syringes and are easier to use and carry.

The market for insulin pens is segmented based on product type, end use, and region.

Insulin pens can be injected in the front and side of thigh, in the abdomen, and in the outer and upper arms.

The primary product types for insulin pens are prefilled and reusable.

The various end uses in the market are hospitals and clinics, ambulatory surgical centres, and home care settings.

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Pricing Plans

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

Strategic Solutions for Informed Decision-Making

Back to top

We’re here to help answer any questions about our products and services.

Contact us

Locations


United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-120-433-0800

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124